Free Patent/Trademark Report to Commissioner - District Court of Delaware - Delaware

Case 1 :08-cv-00164-JJF Document 21 Filed 06/24/2008 Page 1 of 1
%1 AO 120 Rev. 3/04)
TO Mail Stop 8 REPORT ON THE
' Director of the U.S. Patent and Trademark Office FILING OR DETERMINATION OF AN
no. Box 1450 ACTION REGARDING A PATENT on
Alexandria, VA 22313-1450 TRADEMARK
In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1 1 16 you are hereby advised that a court action has been
filed in the U.S. District Court Delaware on the following X Patents or E1 Trademarks:
DOCKET NO. DATE FILED U.S. DISTRICT COURT
08cv164 3/24/2008 DISTRICT OF DELAWARE
PLAINTIFF DEFENDANT
Pfizer Inc., et al. Ranbaxy Laboratories Limited, et al.
PATENT OR DATE OF PATENT
TRADEMARK NO- OR TRADEMARK HOLDER OF PATENT OR TRADEMARK
1 6,087,511 7/1 1/2000 Warner-Lambert Company
2 6,274,740 8/ l 4/2001 Warner-Lambert Company
3
4
5
In the above-entitled case, the 1`ollowing pateni(s)/ trademark(s) have been included:
DATE INCLUDED INCLUDED BY
I:] Amendment [I Answer lj Cross Bill I:] Other Pleading
PATENT OR DATE OF PATENT
TRADEMARK NO. OR TRADEMARK HOLDER OF PATENT OR TRADEMARK
I
2 -_
3
4 __
5
In the above——entit1ed case, the following decision has been rendered orjudgement issued:
DECISION/JUDGEMENT
See Attached Consent Order and Stipulated Injunction
CLERK (BY) DEPUTY CLERK DATE
. E R URT · A. ' ” .
PETER T DALL O, CLE K OF CO V V A, 6/24/2008
Copy l—Upon initiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
Copy 2-—Upon tiling document adding patent(s), mail this copy to Director Copy 4—Case file copy

Case 1 :08-cv-00164-JJF Document 21 -2 Filed 06/24/2008 Page 1 of 3
[N THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
)
Pfizer Inc., )
Pfizer Ireland Pharmaceuticals, )
Warner-Lambert Company, )
Warner-Lambert Company LLC and )
Warner-Lambert Export Limited, )
)
Plaintiffs/Counterclaim-Defendants )
)
v. )
) C.A. No. 08-cv-164-JJF
)
Ranbaxy Laboratories Limited )
Ranbaxy Pharmaceuticals, Inc. and )
Ranbaxy, Inc, )
)
Defendant/Counterclaim-Plaintiff )
)
CONSENT ORDER AND STIPULATED [NJUNCTION
WHEREAS, plaintiffs/counterclaim defendants Pfizer Inc., Pfizer Ireland
Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company, LLC and
Warner-Lambert Export Limited ("Pfizer") own U.S. patents covering the manufacture,
sale and use of atorvastatin containing products, including without limitation U.S. patents
6,087,511 and 6,274,740 (collectively, "Lipitor Patents");
WHEREAS, defendant/counterclaim plaintiff Ranbaxy Laboratories Limited,
Ranbaxy Pharmaceuticals, Inc. and Ranbaxy, Inc. ("Ranbaxy") has submitted to the U.S.
Food and Drug Administration Abbreviated New Drug Application No. 76-477
("Ranbaxy ANDA") for approval to market and sell generic atorvastatin calcium;
WHEREAS, Pfizer and Ranbaxy are parties to litigation relating to the Ranbaxy
ANDA and Lipitor Patents, and Ranbaxy desires to sell generic atorvastatin calcium

Case 1:08-cv-00164-JJF Document 21-2 Filed 06/24/2008 Page 2 of 3
undert he Ranbaxy ANDA free from claims of infringement by Pfizeru ndert he Lipitor
Patents;
WHEREAS, Pfizer andR anbaxy have entered intoa Settlement andL icense
Agreement, dated as of June 17, 2008 ("Settlement Agreement"), pursuant to which the
parties have resolved this action and Pfizer has granted Ranbaxy certain rights to its
portfolio of patents relating to atorvastatin;
NOW THEREFORE, Pfizer and Ranbaxy stipulate that:
1. Ranbaxy, its officers, agents,s ervants, employees and attorneys, and those
persons in active concert or participation with Ranbaxy are enjoined until November 30,
2011 from engaging in the commercial manufacture, use, offer to sell, or sale within the
UnitedS tates, or importationi ntot he UnitedS tates, of any product comprising the
chemical compound atorvastatin calcium. This injunction shall terminate automatically
upon the U.S. Generic Lipitor Commencement Date as defined in the Settlement
Agreement.
2. The Protective Order entered by the Court in this action shall remain in
full force and effect notwithstanding this Consent Order and Stipulated Injunction.
3. All claims and counterclaims are dismissed with prejudice, and each Party
shall bear its own costs, expenses and attorneys’ fees in connection with this action.
4. The parties waive any right of appeal from this Order.
5. The Court reserves jurisdiction over this Consent Order in the evento f any
dispute concerning it.
2

Case 1:08-cv-00164-JJF Document 21-2 Filed 06/24/2008 Page 3 of 3
Dated: June 18,200 8 Dated: June 18, 2008
By: /s/ Rudolf E. Hutz By: /s/ Frederick L. Cottrell, III
Rudelf B Hutz (#484) Frederick nc 6trre11, III (#2555)
Jeffrey B- Beve (#998) ameri; e6¤re11@r1£e6m
MFIYY W- Beurke (#2356) Richards, Layton & Finger
CONNOLLY BOVE LODGE & HUTZ LLP Ono Rodney Sonoio
The Nemours Building p_O_ Box 55i
1007 North Orange Street Wiiniington’ DE igggg
P-Q BOX 2207 (302) 658-6541
Wllmmgtom DE 19899*2207 Attorneys for Defendants
(302) 658-9141
Attorneys for the Plaintmfs Ofconnsoii
Joseph M. Reisman
William R. Zimmerman
Payson LeMeilleur
KNOBBE, MARTENS, OLSON
& BEAR, LLP
2040 Main Street, 14th Floor
Irvine, CA 92614
(949) 760-0404
Attorneysfor Defendants
IT IS SO OIUDERED, this 9`0 day of , 2008.
OJ»v~·e\
e Honora Joseph J. Far , Jr.
ited States District Judge
3

Case 1:08-cv-00164-JJF

Document 21

Filed 06/24/2008

Page 1 of 1

Case 1:08-cv-00164-JJF

Document 21-2

Filed 06/24/2008

Page 1 of 3

Case 1:08-cv-00164-JJF

Document 21-2

Filed 06/24/2008

Page 2 of 3

Case 1:08-cv-00164-JJF

Document 21-2

Filed 06/24/2008

Page 3 of 3